Advertisement
Research Article

TLR1/2 Activation during Heterologous Prime-Boost Vaccination (DNA-MVA) Enhances CD8+ T Cell Responses Providing Protection against Leishmania (Viannia)

  • Asha Jayakumar,

    Affiliation: Yale University School of Public Health, New Haven, Connecticut, United States of America

    X
  • Tiago M. Castilho,

    Affiliation: Yale University School of Public Health, New Haven, Connecticut, United States of America

    X
  • Esther Park,

    Affiliation: Yale University School of Public Health, New Haven, Connecticut, United States of America

    X
  • Karen Goldsmith-Pestana,

    Affiliation: Yale University School of Public Health, New Haven, Connecticut, United States of America

    X
  • Jenefer M. Blackwell,

    Affiliation: Centre for Child Health Research, Telethon Institute for Child Health Research, University of Western Australia, Perth, Australia

    X
  • Diane McMahon-Pratt mail

    diane.mcmahon-pratt@yale.edu

    Affiliation: Yale University School of Public Health, New Haven, Connecticut, United States of America

    X
  • Published: June 14, 2011
  • DOI: 10.1371/journal.pntd.0001204

Reader Comments (0)

Post a new comment on this article